Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents Mubadala Capital in Its Acquisition of Arrive LogisticsAugust 28, 2026Sidley Represents Valiant Integrated Defense Services on Carve-Out Sale of O&M Division to Inspirit EquityAugust 27, 2026Sidley Elevates Cross-Practice Data Centers and Digital Infrastructure Platform for the Next Phase of Digital Infrastructure InvestmentAugust 25, 2026Sidley Represents Rael in Its Strategic Investment from TowerBrook Capital PartnersAugust 24, 2026Sidley Represents Stone Point Capital in Acquisition of Ever.Ag’s Risk Management BusinessAugust 20, 2026Sidley Adds Life Sciences Transactions Partner Jiqiang (JQ) Lin in New YorkAugust 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory